| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 2.58M | 16 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 11 Apr 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 15 Apr 2025, 17:42 |
| KYTX | Kyverna Therapeutics, Inc. | 16 Sep 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 18 Sep 2024, 21:18 |
| KYTX | Kyverna Therapeutics, Inc. | 16 Sep 2024 | 0 | $0 | 3 | Chief Executive Officer, Director | 18 Sep 2024, 21:15 |